Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Commission's secretive tobacco lobby contacts breach UN rules - Ombudsman

The EU Ombudsman has upheld a complaint by Corporate Europe Observatory (CEO) against the Commission over its failure to implement UN tobacco lobby rules.

Deeming the Commission's failure to comply with the World Health Organisation's (WHO) Framework Convention on Tobacco Control as 'maladministration', Ombudsman Emily O'Reilly has urged the Commission to publish details of all meetings with tobacco lobbyists online. O'Reilly also asked the Commission for an update on its promise to introduce a mandatory transparency register for lobbyists.

The EU is a signatory to Article 5.3 of the WHO's Framework Convention on Tobacco Control, which is intended to protect decision-making "from commercial and other vested interests of the tobacco industry". It thus obliges governments to limit interactions with the tobacco industry and ensures the transparency of those interactions that do occur. In May 2014, CEO submitted a complaint about the Commission's failure to properly implement these rules. The resulting Ombudsman probe involved an inspection of official files and staff agendas at the Commission's HQ, the Berlaymont, to identify possible meetings with tobacco lobbyists.

The Ombudsman's investigation found that a top official from the Commission's legal service had declared no meetings with tobacco industry representatives despite having meetings with a lawyer working for tobacco giant Philip Morris. The Commission's contacts with the tobacco industry attracted major controversy following revelations of heavy lobbying pressure during the 2012-2014 revision of the EU's tobacco products directive, including the 'Dalligate' scandal, which involved the forced resignation of then EU health commissioner John Dalli in October 20131.

“This ruling is a significant victory for the fight against the sinister scheming of this lethal industry,” said CEO's research and campaigns coordinator Olivier Hoedeman. “The Commission's complacency and secrecy over its contacts with the tobacco industry are deeply regrettable - but part of a pattern. We hope it will finally get the message that it must fulfil its UN obligations and take strong measures to prevent the undue influence of tobacco lobbyists. The Commission must now implement WHO Convention rules across all departments, publish details and minutes of all meetings with tobacco industry representatives and introduce a mandatory lobby transparency register to ensure that tobacco industry lobbyists are forced to disclose information about their lobbying.”

The new ruling follows other, recent Ombudsman rulings on several other CEO complaints about secrecy and conflicts of interests emerging from the Commission's relations with tobacco industry. In December 2013, the Ombudsman slammed the Commission for its failure to act against Michel Petite, a lawyer at law firm Clifford Chance whose clients include Philip Morris, and who was simultaneously acting as head of the committee which advises on whether the Commission should authorise the new professional activities of ex-commissioners.

Link to ruling: http://www.ombudsman.europa.eu/cases/draftrecommendation.faces/en/61021/...

Background:

http://corporateeurope.org/power-lobbies/2014/07/ombudsman-investigates-eu-commissions-failure-implement-un-tobacco-lobby-rules

http://corporateeurope.org/sites/default/files/attachments/complaint_about_failure_to_implement_who_rules_re_tobacco_lobbying.pdf

http://corporateeurope.org/power-lobbies/2014/10/will-barroso-provide-answers-about-tobacco-industry-contacts-leaving

http://corporateeurope.org/pressreleases/2013/12/ngos-welcome-replacement-controversial-michel-petite-commission-needs-far

Contacts:

Olivier Hoedeman: 0032 474486545 / 0032 28930930

Related issues: 
 

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

In the run up to the UK referendum on EU membership on 23 June, Corporate Europe Observatory has tabled a series of freedom of information requests to find out how UK finance lobbies have been influencing the referendum negotiations and the Capital Markets Union. But the Brexit-Bremain referendum seems to be a freedom of information black hole.

From the day a referendum on UK membership of the EU was first announced in 2013, the financial sector started using Cameron’s re-negotiation process to promote its deregulatory agenda. Sometimes lobbying was required, but more often the UK government did its work for them. 

A new report on carbon market reform has kicked off debate on the issue in the European Parliament. It promises new loopholes for the oil industry and other polluters.

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

While CEO is not taking a position on the UK referendum, many of our publications are relevant to those who will have a vote, or those who are following the debate.

Biodiversity collapse, the future of agriculture, politics versus science, EU States and the European Commission shifting blame on each other, industry's capture of the regulatory process through data secrecy, a Commissioner caught between Juncker, EU States, lobby groups, and his own services... The glyphosate saga, coming to the end of its first phase tomorrow, has been an entry point into many broader problems. Overview.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

The corporate lobby tour